Alexza Pharmaceuticals, Inc.(Other OTC/NBB : ALXA)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | -0.25% | 158.92 | 0.7% | $1251.69m | |
| PFE | Pfizer Inc. | 0.06% | 33.55 | 0.9% | $1146.07m | |
| MRK | Merck & Co., Inc. | 0.57% | 72.79 | 0.7% | $838.26m | |
| BMY | Bristol-Myers Squibb Co. | -0.63% | 61.24 | 1.0% | $812.59m | |
| ABBV | AbbVie, Inc. | -0.54% | 107.83 | 1.9% | $755.30m | |
| LLY | Eli Lilly & Co. | -1.04% | 204.32 | 1.1% | $671.62m | |
| AZN | AstraZeneca Plc | -0.75% | 47.73 | 1.2% | $504.47m | |
| GSK | GlaxoSmithKline Plc | 1.07% | 34.09 | 0.2% | $276.75m | |
| NVS | Novartis AG | 1.85% | 88.17 | 0.2% | $176.09m | |
| SNY | Sanofi | 0.07% | 45.94 | 0.2% | $161.63m | |
| VTRS | Viatris, Inc. | -2.92% | 14.29 | 0.0% | $145.44m | |
| VERU | Veru, Inc. | -2.78% | 14.01 | 0.0% | $116.99m | |
| CVAC | CureVac NV | -3.47% | 92.84 | 0.0% | $90.70m | |
| NVO | Novo Nordisk A/S | 0.01% | 72.65 | 0.1% | $89.13m | |
| RPRX | Royalty Pharma Plc | -2.25% | 46.95 | 0.2% | $85.82m |
Company Profile
Alexza Pharmaceuticals is an emerging specialty pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions. It was founded in 2001 and headquartered in Mountain View, California.